University Professor / Group Leader
BIH - Si-M / Charité-Universitätsmedizin Berlin
Berlin, Berlin, Germany
SHORT BIOGRAPHY - Prof. rer. nat. Andreas Thiel
• CURRENT POSITION(S)
2018 – Charité coordinator and spokesman* of the „Der Simulierte Mensch“ (Si-M).
since 2009 W2 Professor for Regenerative Immunology and Aging at the Berlin- Brandenburg Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin
since 2022 BIH (Berlin Institute for Health) Immunomics, Charité Universitätsmedizin Berlin
• ACTIVITIES
2017-2026* §91b joint grant application with the TU Berlin for a new research building `Der Simulierte Mensch´ (Si-M) (34 Mill €)
• PATENTS (major patents)
US 7,659,084 B2
US 2010/0055720 A1
• Books
Editor: Immunesenescence, 2012, Birkhäuser Advances in Infectious Diseases, Springer Verlag
RELEVANT PUBLICATIONS
1. Loyal L, et al., Thiel A, and C. Giesecke-Thiel, Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science, 2021
2. Loyal L, et al., and A. Thiel. SLAMF7 and IL-6R define distinct cytotoxic versus helper memory CD8+ T cells. Nat Commun, 2020
3. Braun J, Loyal L, Frentsch M, et al., Giesecke-Thiel C, Sander LE and A. Thiel. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature, 2020
4. Schulz AR, et al., A. Thiel. J Immunol, 2015
5. Frentsch M, et al., A. Thiel. Blood, 2013
7. Schoenbrunn A, et al., A. Thiel. 2012. J Immunol, 2012
8. Kohler S and A. Thiel. Blood, 2009
9. Frentsch M, et al., A. Thiel. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med, 2005
10. Kimmig S., et al., A. Thiel. J Exp Med, 2002
Disclosure information not submitted.
Wednesday, June 22, 2022
2:20 PM – 2:45 PM PT
